Brought to you by 
Quanterix completes $15mm two-tranche Series A
08 Apr 2009
Executive Summary
Quanterix (single-molecule detection platform for diagnostics and research applications) has closed a $15mm two-tranche Series A venture round co-led by Arch Venture Partners, Bain Capital Ventures, and Flagship Ventures.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Quanterix completes $15mm two-tranche Series A
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice